mustangbio.com - MBIO Earnings growth forecast for next year

Corporate company logo of Mustang Bio Inc (MBIO)

Cost optimization through asset sales is driving growth, which is supported by the projected increase in EPS for the coming year. The value of 0.00 reflects the current volume of this metric. The business foundation of Mustang Bio, Inc. (MBIO) relies on alliances with oncology centers to develop CAR-T therapy, while success depends on the scaling of biomanufacturing and venture capital.

MBIO: Mustang Bio Corp Consensus forecast of earnings per share growth for next year 07/04/2022 - 11/16/2026

Mustang Bio Inc - analytical breakdowns and key metrics (MBIO)

- stock quotes and analyst forecast:
Initial company analysis:MBIO, Mustang Bio Corp
Brand item of Mustang Bio

To assess the credit quality of Mustang Bio, Inc. (MBIO), the analyst compares market expectations with actual capitalization rates. Unique patents in CAR-T therapy create a defensive barrier that should convert into financial stability. This daily price chart of the consensus EPS n+1 forecast reflects the daily revaluation of future earnings, where increased indicator volatility warns investors of business model uncertainty and potential risks of a deep asset drawdown.

Competing companies

TEM (Tempus) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year QGEN (Qiagen)|Earnings growth forecast for next year IONS|RGEN (Repligen) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year aviditybiosciences.com RNA|CRISPR (CRSP) - Expected net earnings per share growth next year|genedx.com - Earnings growth forecast for next year|Expected earnings per share trend next year RARE (ultragenyx.com)|BEAM: Earnings growth forecast for next year|Sarepta - Expected earnings per share trend next year|TWST (twistbioscience.com) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year TXG (10x Genomics Corp)|Earnings growth forecast for next year NTLA|Earnings growth forecast for next year Stoke Therapeutics, Inc. (STOK)|Net earnings per share growth forecast for next year BioLife BLFS|WVE - Expected earnings per share growth for next year|Maze Therapeutics Corp - Earnings growth forecast for next year|Sionna Pharma - Projected earnings per share increase next year|Prime Medicine (PRME) - Net earnings per share growth forecast for next year|tayshagtx.com (TSHA) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year uniQure Corp|MGTX: Expected earnings per share trend next year|Earnings growth forecast for next year RGNX|Consensus forecast of earnings per share growth for next year Solid Corp|Earnings growth forecast for next year OCGN (ocugen.com)|PACB (Pacific Biosciences) - Net earnings per share change forecast for next year|Benitec Biopharma Inc - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Net earnings per share growth forecast for next year|4D Molecular Therapeutics (FDMT) - Earnings growth forecast for next year|LXEO (Lexeo Therapeutics, Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year korrobio.com KRRO|Expected earnings per share growth for next year EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year ProQR Therapeutics N.V. PRQR|Consensus forecast of earnings per share growth for next year Codexis, Inc. (CDXS)|SGMO - Net earnings per share growth forecast for next year|nautilus.bio - Projected earnings per share increase next year|Metagenomi, Inc (MGX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year DTIL|Net earnings per share growth forecast for next year Generation Bio|Earnings growth forecast for next year Boundless Bio Inc|Net earnings per share growth forecast for next year Exicure Corp (XCUR)|Consensus forecast of earnings per share growth for next year Imunon|Earnings growth forecast for next year PHIO (phiopharma.com)|Projected earnings per share increase next year RNAZ (TransCode Therapeutics)|BNGO - Net earnings per share growth forecast for next year|APDN: Net earnings per share growth forecast for next year|BLUE: Earnings growth forecast for next year|Expected earnings per share growth for next year ImmunoPrecise Antibodies|OMGA (Omega Therapeutics, Inc.) - Earnings growth forecast for next year|Singular Genomics (OMIC) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Regulus (RGLS)|SYRS (Syros Pharmaceuticals, Inc) - Expected earnings per share trend next year|Telesis Bio, Inc. - Expected earnings per share growth for next year|TCON: Projected earnings per share growth rate for next year|Unity Biotechnology Inc. - Earnings growth forecast for next year